Logo image of BLBD

BLUE BIRD CORP (BLBD) Stock Fundamental Analysis

NASDAQ:BLBD - Nasdaq - US0953061068 - Common Stock - Currency: USD

42.75  -0.11 (-0.26%)

After market: 42.75 0 (0%)

Fundamental Rating

6

BLBD gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 127 industry peers in the Machinery industry. Both the profitability and the financial health of BLBD get a neutral evaluation. Nothing too spectacular is happening here. BLBD scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make BLBD a good candidate for value investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

BLBD had positive earnings in the past year.
In the past year BLBD had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BLBD reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: BLBD reported negative operating cash flow in multiple years.
BLBD Yearly Net Income VS EBIT VS OCF VS FCFBLBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

With an excellent Return On Assets value of 19.89%, BLBD belongs to the best of the industry, outperforming 99.21% of the companies in the same industry.
Looking at the Return On Equity, with a value of 56.80%, BLBD belongs to the top of the industry, outperforming 97.64% of the companies in the same industry.
The Return On Invested Capital of BLBD (28.98%) is better than 98.43% of its industry peers.
Industry RankSector Rank
ROA 19.89%
ROE 56.8%
ROIC 28.98%
ROA(3y)4.43%
ROA(5y)3.41%
ROE(3y)-1048.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLBD Yearly ROA, ROE, ROICBLBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

The Profit Margin of BLBD (7.97%) is better than 61.42% of its industry peers.
In the last couple of years the Profit Margin of BLBD has grown nicely.
BLBD has a Operating Margin (9.74%) which is in line with its industry peers.
In the last couple of years the Operating Margin of BLBD has grown nicely.
With a Gross Margin value of 19.18%, BLBD is not doing good in the industry: 74.80% of the companies in the same industry are doing better.
BLBD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.74%
PM (TTM) 7.97%
GM 19.18%
OM growth 3Y121.61%
OM growth 5Y19.19%
PM growth 3YN/A
PM growth 5Y26.86%
GM growth 3Y21.73%
GM growth 5Y7.73%
BLBD Yearly Profit, Operating, Gross MarginsBLBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

More info and screens

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), BLBD is creating value.
BLBD has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BLBD has been increased compared to 5 years ago.
BLBD has a better debt/assets ratio than last year.
BLBD Yearly Shares OutstandingBLBD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BLBD Yearly Total Debt VS Total AssetsBLBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 5.88 indicates that BLBD is not in any danger for bankruptcy at the moment.
BLBD has a better Altman-Z score (5.88) than 82.68% of its industry peers.
BLBD has a debt to FCF ratio of 1.07. This is a very positive value and a sign of high solvency as it would only need 1.07 years to pay back of all of its debts.
The Debt to FCF ratio of BLBD (1.07) is better than 85.04% of its industry peers.
BLBD has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
BLBD has a Debt to Equity ratio (0.46) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 1.07
Altman-Z 5.88
ROIC/WACC2.92
WACC9.92%
BLBD Yearly LT Debt VS Equity VS FCFBLBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

2.3 Liquidity

BLBD has a Current Ratio of 1.45. This is a normal value and indicates that BLBD is financially healthy and should not expect problems in meeting its short term obligations.
BLBD has a Current ratio of 1.45. This is in the lower half of the industry: BLBD underperforms 77.95% of its industry peers.
A Quick Ratio of 0.73 indicates that BLBD may have some problems paying its short term obligations.
BLBD's Quick ratio of 0.73 is on the low side compared to the rest of the industry. BLBD is outperformed by 83.46% of its industry peers.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 0.73
BLBD Yearly Current Assets VS Current LiabilitesBLBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

5

3. Growth

3.1 Past

BLBD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.76%, which is quite impressive.
The Earnings Per Share has been growing by 16.38% on average over the past years. This is quite good.
BLBD shows a small growth in Revenue. In the last year, the Revenue has grown by 7.57%.
The Revenue has been growing slightly by 5.74% on average over the past years.
EPS 1Y (TTM)22.76%
EPS 3Y123.91%
EPS 5Y16.38%
EPS Q2Q%7.87%
Revenue 1Y (TTM)7.57%
Revenue growth 3Y25.35%
Revenue growth 5Y5.74%
Sales Q2Q%3.74%

3.2 Future

Based on estimates for the next years, BLBD will show a small growth in Earnings Per Share. The EPS will grow by 6.83% on average per year.
BLBD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.99% yearly.
EPS Next Y11.4%
EPS Next 2Y10.42%
EPS Next 3Y6.83%
EPS Next 5YN/A
Revenue Next Year9.16%
Revenue Next 2Y8.58%
Revenue Next 3Y5.57%
Revenue Next 5Y6.99%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BLBD Yearly Revenue VS EstimatesBLBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
BLBD Yearly EPS VS EstimatesBLBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 3 4

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.01 indicates a correct valuation of BLBD.
BLBD's Price/Earnings ratio is rather cheap when compared to the industry. BLBD is cheaper than 88.98% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.50, BLBD is valued rather cheaply.
A Price/Forward Earnings ratio of 10.07 indicates a reasonable valuation of BLBD.
Based on the Price/Forward Earnings ratio, BLBD is valued cheaply inside the industry as 90.55% of the companies are valued more expensively.
BLBD's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.44.
Industry RankSector Rank
PE 12.01
Fwd PE 10.07
BLBD Price Earnings VS Forward Price EarningsBLBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BLBD is valued cheaply inside the industry as 81.10% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, BLBD is valued a bit cheaper than 77.95% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.46
EV/EBITDA 8.93
BLBD Per share dataBLBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

BLBD's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
BLBD has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.05
PEG (5Y)0.73
EPS Next 2Y10.42%
EPS Next 3Y6.83%

More info and screens

0

5. Dividend

5.1 Amount

BLBD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BLUE BIRD CORP

NASDAQ:BLBD (7/18/2025, 8:00:01 PM)

After market: 42.75 0 (0%)

42.75

-0.11 (-0.26%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners118.16%
Inst Owner Change0%
Ins Owners0.58%
Ins Owner Change0.94%
Market Cap1.35B
Analysts83.08
Price Target52.6 (23.04%)
Short Float %16.05%
Short Ratio12.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.87%
Min EPS beat(2)-0.8%
Max EPS beat(2)10.53%
EPS beat(4)3
Avg EPS beat(4)24.77%
Min EPS beat(4)-0.8%
Max EPS beat(4)74.11%
EPS beat(8)7
Avg EPS beat(8)53.29%
EPS beat(12)9
Avg EPS beat(12)-95.09%
EPS beat(16)10
Avg EPS beat(16)-86.39%
Revenue beat(2)0
Avg Revenue beat(2)-0.57%
Min Revenue beat(2)-0.95%
Max Revenue beat(2)-0.19%
Revenue beat(4)1
Avg Revenue beat(4)0.55%
Min Revenue beat(4)-0.95%
Max Revenue beat(4)3.87%
Revenue beat(8)5
Avg Revenue beat(8)4.08%
Revenue beat(12)8
Avg Revenue beat(12)5.72%
Revenue beat(16)10
Avg Revenue beat(16)4.68%
PT rev (1m)0%
PT rev (3m)-2.7%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.69%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.65%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.75%
Valuation
Industry RankSector Rank
PE 12.01
Fwd PE 10.07
P/S 1
P/FCF 15.46
P/OCF 12.21
P/B 7.09
P/tB 10.47
EV/EBITDA 8.93
EPS(TTM)3.56
EY8.33%
EPS(NY)4.24
Fwd EY9.93%
FCF(TTM)2.76
FCFY6.47%
OCF(TTM)3.5
OCFY8.19%
SpS42.96
BVpS6.03
TBVpS4.08
PEG (NY)1.05
PEG (5Y)0.73
Profitability
Industry RankSector Rank
ROA 19.89%
ROE 56.8%
ROCE 41.65%
ROIC 28.98%
ROICexc 49.31%
ROICexgc 73.58%
OM 9.74%
PM (TTM) 7.97%
GM 19.18%
FCFM 6.44%
ROA(3y)4.43%
ROA(5y)3.41%
ROE(3y)-1048.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y220.13%
ROICexcg growth 5Y10.5%
ROICexc growth 3Y207.87%
ROICexc growth 5Y19.73%
OM growth 3Y121.61%
OM growth 5Y19.19%
PM growth 3YN/A
PM growth 5Y26.86%
GM growth 3Y21.73%
GM growth 5Y7.73%
F-Score8
Asset Turnover2.49
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 1.07
Debt/EBITDA 0.59
Cap/Depr 152.12%
Cap/Sales 1.71%
Interest Coverage 12.82
Cash Conversion 75.01%
Profit Quality 80.71%
Current Ratio 1.45
Quick Ratio 0.73
Altman-Z 5.88
F-Score8
WACC9.92%
ROIC/WACC2.92
Cap/Depr(3y)67.41%
Cap/Depr(5y)84.95%
Cap/Sales(3y)0.9%
Cap/Sales(5y)1.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.76%
EPS 3Y123.91%
EPS 5Y16.38%
EPS Q2Q%7.87%
EPS Next Y11.4%
EPS Next 2Y10.42%
EPS Next 3Y6.83%
EPS Next 5YN/A
Revenue 1Y (TTM)7.57%
Revenue growth 3Y25.35%
Revenue growth 5Y5.74%
Sales Q2Q%3.74%
Revenue Next Year9.16%
Revenue Next 2Y8.58%
Revenue Next 3Y5.57%
Revenue Next 5Y6.99%
EBIT growth 1Y7.72%
EBIT growth 3Y177.79%
EBIT growth 5Y26.04%
EBIT Next Year39.1%
EBIT Next 3Y15.18%
EBIT Next 5Y14.15%
FCF growth 1Y249.42%
FCF growth 3YN/A
FCF growth 5Y36.54%
OCF growth 1Y248.76%
OCF growth 3YN/A
OCF growth 5Y14.81%